Benavides, F.F.W., Kempff, A.L.V., Smeenk, H. et a. Influenza A virus infection impairs neuronal activity in human iPSC-derived NGN2 neural co-cultures. acta neuropathol commun (2026)
Influenza A virus (IAV) infection is associated with a wide variety of neurological complications, of which mild complications like impaired cognitive functioning are most prominent. Even though several studies have shown that many influenza viruses can enter the CNS, the neuropathogenesis of seasonal (H3N2 and H1N1) and pandemic (pH1N1 2009) IAV infections is poorly understood. Therefore, we aimed to investigate the cellular tropism, replication efficiency and associated functional consequences using a human stem cell-derived neural co-culture model of neurons and astrocytes. All viruses were able to infect neurons in the co-culture model, although this infection did not result in efficient replication and release of progeny virus. In addition, infection did not result in visible cell death or apoptosis. However, functional analyses revealed that IAV inoculation resulted in a reduction of spontaneous neural activity and a partial reduction of neural excitability. This study shows that seasonal and pandemic IAVs can disrupt neural homeostasis, without efficient virus replication or the induction of cell death. These functional changes in neural activity can contribute to cognitive problems during IAV infections in the acute and potentially post-acute phase of the infection.
See Also:
Latest articles in those days:
- Avian Influenza in Humans: Virology, Transmission, and Clinical Priorities 15 hours ago
- Global influenza epidemiology after 2020: patterns of circulation, epidemic timing and duration, and implications for vaccination strategies 1 days ago
- Coding complete genome of LPAI H16N3 virus from Australia suggests intercontinental movement 2 days ago
- Detection of antibodies to avian influenza virus H5N1 clade 2.3.4.4b in naturally infected cattle for more than a year 2 days ago
- A C-type single-domain antibody with protective efficacy against H1N1 via respiratory administration 2 days ago
[Go Top] [Close Window]


